Treating Concurrent Substance Use Among Adults (2 credit hours)

Program Summary:   This course provides an overview of concurrent substance use and concurrent substance use disorder, exploring risk factors, protective factors, screening, assessment, and treatment.  Three treatment approaches are examined including FDA-approved pharmacotherapy with counseling, contingency management with FDA-approved pharmacotherapy and counseling, and twelve-step facilitation therapy with FDA-approved pharmacotherapy and counseling.  Strategies for managing clinical issues are given.

This course is recommended for social workers and counselors and is appropriate for beginning and intermediate levels of practice.  

 Open the Course Reading Here.

Course Reading:  Treating Concurrent Substance Use Among Adults; Chapters 1-3

Publisher:  SAMHSA

Course Objectives:  To enhance professional practice, values, skills and knowledge by exploring the treatment of concurrent substance use among adults.

Learning Objectives:  Describe risk and protective factors that influence concurrent substance use among adults.  Identify treatment approaches for concurrent substance use among adults.  Describe strategies for managing clinical issues and challenges.

Review our pre-reading study guide.

Course Available Until: September 30, 2026.

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

1: Chapter 1: Most research that examines substance use addresses the use and treatment of
 
 
2: Individuals use more than one substance in order to
 
 
 
 
 
3: The consumption of more than one substance within a short period of time, including alcohol and drugs describes
 
 
 
 
4: Which of the following is a protective factor that serves as a barrier to an individual developing an SUD?
 
 
 
 
 
5: People who use alcohol and marijuana together are ___________ likely to drive while impaired than those who did not use both together.
 
 
6: Chapter 2: Which approach includes the use of FDA-approved medications to help reduce substance use?
 
 
 
7: Which approach includes behavioral interventions grounded in operant conditioning theory?
 
 
 
8: Which approach has treatment goals of acceptance and surrender?
 
 
 
9: Chapter 3:  Meeting individuals where they are is a management strategy for
 
 
 
 
10: Considering integrated treatment options is a management strategy for
 
 
 
 
11: Those with CSU and concurrent SUD often have ___________ rates of treatment retention and completion.
 
 
12: Individuals with CSU and concurrent SUD often exhibit _____________ severe risk factors than individuals with a single SUD.
 
 
13: Which of the following considers a client's past and current life situation in the delivery of care and builds on a client's strengths to promote healing and recovery?
 
 
 
 
14: Which of the following is an example of a harm reduction strategy?
 
 
 
 
15: Treatment practices have often been designed for and evaluated with predominantly
 
 
 
 
16: A diverse workforce will improve
 
 
 
 
 
17: It is important to maintain ________________ in order to fit the treatment to a client's unique needs and to avoid compromising expected treatment outcomes.
 
 
 

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

G.M. Rydberg-Cox, MSW, LSCSW is the Continuing Education Director at Free State Social Work and responsible for the development of this course.  She received her Masters of Social Work in 1996 from the Jane Addams School of Social Work at the University of Illinois-Chicago and she has over 20 years of experience.  She has lived and worked as a social worker in Chicago, Boston, and Kansas City. She has practiced for many years in the area of hospital/medical social work.  The reading materials for this course were developed by another organization.

Course Available Until: September 30, 2026.
Filed under: Addiction, Clinical